SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-007816
Filing Date
2016-08-09
Accepted
2016-08-09 16:30:58
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20160630x10q.htm 10-Q 1352441
2 EX-31.1 axsm-20160630ex3114595d1.htm EX-31.1 16752
3 EX-31.2 axsm-20160630ex312a088a3.htm EX-31.2 16298
4 EX-32.1 axsm-20160630ex321bc5289.htm EX-32.1 6390
5 EX-32.2 axsm-20160630ex322ac5d0c.htm EX-32.2 6213
  Complete submission text file 0001558370-16-007816.txt   3499537

Data Files

Seq Description Document Type Size
6 EX-101.INS axsm-20160630.xml EX-101.INS 576781
7 EX-101.SCH axsm-20160630.xsd EX-101.SCH 19678
8 EX-101.CAL axsm-20160630_cal.xml EX-101.CAL 23252
9 EX-101.DEF axsm-20160630_def.xml EX-101.DEF 54681
10 EX-101.LAB axsm-20160630_lab.xml EX-101.LAB 210406
11 EX-101.PRE axsm-20160630_pre.xml EX-101.PRE 147603
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 161818379
SIC: 2834 Pharmaceutical Preparations